Developmental ablation of Id1 and Id3 genes in the vasculature leads to postnatal cardiac phenotypes

Developmental Biology

Volumn 349, Issue 1, 2011, Pages 53-64

  Zhao, Qingshi ^a   Beck, Amanda J ^a   Vitale, Joseph M ^a   Schneider, Joel S ^a   Gao, Shumin ^a   Chang, Corey ^a   Elson, Genie ^a   Leibovich, Samuel J ^a   Park, Ji Yeon ^a   Tian, Bin ^a   Nam, Hyung Song ^b   Fraidenraich, Diego ^a,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiogenesis; Angiopoietin; Cardiomyopathy; Conditional knockout; Fibrosis; Thrombospondin; Trabeculation; Ventricular septal defects

Indexed keywords

CRE RECOMBINASE; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 3; SOMATOMEDIN BINDING PROTEIN 3; THROMBOSPONDIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMEGALY; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION PROFILING; HEART DEVELOPMENT; HEART DISEASE; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE SEPTUM DEFECT; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VASCULARIZATION;

MUS;

EID: 78649447206     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2010.10.004     Document Type: Article

References (45)

1. Bai G., Sheng N., Xie Z., Bian W., Yokota Y., Benezra R., Kageyama R., Guillemot F., Jing N. Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1. Dev. Cell 2007, 13:283-297.
2. Brocker C.N., Vasiliou V., Nebert D.W. Evolutionary divergence and functions of the ADAM and ADAMTS gene families. Hum. Genomics 2009, 4:43-55.
3. Chien K.R., Olson E.N. Converging pathways and principles in heart development and disease: CV@CSH. Cell 2002, 110:153-162.
4. Chien K.R., Moretti A., Laugwitz K.L. Development. ES cells to the rescue. Science 2004, 306:239-240.
5. Ciarrocchi A., Jankovic V., Shaked Y., Nolan D.J., Mittal V., Kerbel R.S., Nimer S.D., Benezra R. Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS ONE 2007, 2:e1338.
6. Cubbage M.L., Suwanichkul A., Powell D.R. Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. J. Biol. Chem. 1990, 265:12642-12649.
7. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1169.
8. Di K., Ling M.T., Tsao S.W., Wong Y.C., Wang X. Id-1 modulates senescence and TGF-beta1 sensitivity in prostate epithelial cells. Biol. Cell 2006, 98:523-533.
9. Doran, A. C., Lehtinen, A. B., Meller, N., Lipinski, M. J., Slayton, R. P., Oldham, S. N., Skaflen, M. D., Yeboah, J., Rich, S. S., Bowden, D. W., McNamara, C. A., 2010. Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans. Circ Res. 106, 1303-11.
10. Folkman J. Angiogenesis inhibitors generated by tumors. Mol. Med. 1995, 1:120-122.
11. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
12. Fraidenraich D., Benezra R. Embryonic stem cells prevent developmental cardiac defects in mice. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3(Suppl 1):S14-S17.
13. Fraidenraich D., Stillwell E., Romero E., Wilkes D., Manova K., Basson C.T., Benezra R. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells. Science 2004, 306:247-252.
14. Framson P., Bornstein P. A serum response element and a binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene. J. Biol. Chem. 1993, 268:4989-4996.
15. Gardner D.G. Natriuretic peptides: markers or modulators of cardiac hypertrophy?. Trends Endocrinol. Metab. 2003, 14:411-416.
16. Good D.J., Polverini P.J., Rastinejad F., Le Beau M.M., Lemons R.S., Frazier W.A., Bouck N.P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6624-6628.
17. Granata R., Trovato L., Lupia E., Sala G., Settanni F., Camussi G., Ghidoni R., Ghigo E. Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J. Thromb. Haemost. 2007, 5:835-845.
18. Guo C., Wang Y., Liang H., Zhang J. ADAMTS-1 contributes to the antifibrotic effect of captopril by accelerating the degradation of type I collagen in chronic viral myocarditis. Eur. J. Pharmacol. 2010, 629:104-110.
19. Jen Y., Manova K., Benezra R. Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev. Dyn. 1996, 207:235-252.
20. Jen Y., Manova K., Benezra R. Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev. Dyn. 1997, 208:92-106.
21. Jogie-Brahim S., Feldman D., Oh Y. Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr. Rev. 2009, 30:417-437.
22. Kastner P., Mark M., Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?. Cell 1995, 83:859-869.
23. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 2001, 230:230-242.
24. Lee J.Y., Kang M.B., Jang S.H., Qian T., Kim H.J., Kim C.H., Kim Y., Kong G. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition. Oncogene 2009, 28:824-831.
25. Lehman J.J., Kelly D.P. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin. Exp. Pharmacol. Physiol. 2002, 29:339-345.
26. Lin, J., Guan, Z., Wang, C., Feng, L., Zheng, Y., Caicedo, E., Bearth, E., Peng, J. R., Gaffney, P., Ondrey, F. G., 2010. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res. 16, 77-87.
27. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
28. Lyden D., Young A.Z., Zagzag D., Yan W., Gerald W., O'Reilly R., Bader B.L., Hynes R.O., Zhuang Y., Manova K., Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999, 401:670-677.
29. Murphy L.J., Rajkumar K., Molnar P. Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice. Prog. Growth Factor Res. 1995, 6:425-432.
30. Nam H.S., Benezra R. High levels of Id1 expression define B1 type adult neural stem cells. Cell Stem Cell 2009, 5:515-526.
31. Peter P.S., Brady J.E., Yan L., Chen W., Engelhardt S., Wang Y., Sadoshima J., Vatner S.F., Vatner D.E. Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor. J. Clin. Invest. 2007, 117:1335-1343.
32. Pucci A., Zanini C., Granata R., Ghignone R., Iavarone A., Broglio F., Sorrentino P., Bergamasco L., Rinaldi M., Ghigo E. Myocardial insulin-like growth factor-1 and insulin-like growth factor binding protein-3 gene expression in failing hearts harvested from patients undergoing cardiac transplantation. J. Heart Lung Transplant. 2009, 28:402-405.
33. Rajabi M., Kassiotis C., Razeghi P., Taegtmeyer H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 2007, 12:331-343.
34. Rajah R., Valentinis B., Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 1997, 272:12181-12188.
35. Ruwhof C., van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc. Res. 2000, 47:23-37.
36. Ruzinova M.B., Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 2003, 13:410-418.
37. Schneider J.S., Vitale J.M., Terzic A., Fraidenraich D. Blastocyst injection of embryonic stem cells: a simple approach to unveil mechanisms of corrections in mouse models of human disease. Stem Cell Rev. Rep. 2009, 5(4):369-377.
38. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
39. Sucov H.M., Dyson E., Gumeringer C.L., Price J., Chien K.R., Evans R.M. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 1994, 8:1007-1018.
40. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
41. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
42. Vikkula M., Boon L.M., Carraway K.L., Calvert J.T., Diamonti A.J., Goumnerov B., Pasyk K.A., Marchuk D.A., Warman M.L., Cantley L.C., Mulliken J.B., Olsen B.R. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996, 87:1181-1190.
43. Volpert O.V., Pili R., Sikder H.A., Nelius T., Zaichuk T., Morris C., Shiflett C.B., Devlin M.K., Conant K., Alani R.M. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2002, 2:473-483.
44. Yamamoto S., Yang G., Zablocki D., Liu J., Hong C., Kim S.J., Soler S., Odashima M., Thaisz J., Yehia G., Molina C.A., Yatani A., Vatner D.E., Vatner S.F., Sadoshima J. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J. Clin. Invest. 2003, 111:1463-1474.
45. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W.Z., Mori C., Shiota K., Yoshida N., Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:407-411.